Workflow
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Globenewswire· 2025-12-19 21:05
Nyxoah Announces Issuance of First Tranche of Convertible Bonds Mont-Saint-Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the issuance of the first tranche of the convertible bond financing entered into with an entity managed by Heights Capi ...
Capital One Financial Corporation to Webcast Conference Call on Fourth Quarter 2025 Earnings
Businesswire· 2025-12-19 21:05
MCLEAN, Va.--(BUSINESS WIRE)--On Thursday, January 22, 2026, at approximately 4:05 p.m. Eastern Time, Capital One Financial Corporation (NYSE: COF) will release its fourth quarter 2025 earnings results. Additionally, the company will host a conference call at 5:00 p.m. Eastern Time to review financial and operating performance for the quarter ending December 31, 2025. Capital One Financial Corporation (www.capitalone.com) is a financial holding company which, along with its subsidiaries, had $468.8 billion ...
Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2026 Financial Results
Prnewswire· 2025-12-19 21:05
Revenue Increased by 94.3% YoY; Gross Profit Increased by 29.8% YoY TOKYO, Dec. 19, 2025 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy toys as well as other products in Hong Kong, Japan, North America, Thailand, Vietnam, the United Kingdom and Australia, today announced its unaudited financial results for the first ...
Lifeward Appoints Bob Marshall as Chairman of the Board
Globenewswire· 2025-12-19 21:05
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that its Board of Directors has appointed Bob Marshall as Chairman of the Board, effective January 1, 2026. He replaces Joseph Turk, who will transition off the Board in connection with his new position at Fresenius Medic ...
Pixelworks to Reconvene Special Meeting of Shareholders on December 31, 2025
Prnewswire· 2025-12-19 21:05
When the Special Meeting was reconvened on December 19, 2025, approximately 98% of the proxies that have been received had been voted in favor of Proposal 1, but represented only approximately 61% of the shares of common stock outstanding on the record date for the Special Meeting. The Board of Directors continues to believe that the approval of Proposal 1 is in the best interests of the Company and its shareholders, and the Board of Directors and both leading independent proxy voting advisory groups, Insti ...
Franklin Templeton Canada Announces Estimated December ETF Cash Distributions and Annual Reinvested Distributions - Franklin Resources (NYSE:BEN)
Benzinga· 2025-12-19 21:05
TORONTO, Dec. 19, 2025 /CNW/ - Franklin Templeton Canada today announced the estimated December 2025 cash distributions and the annual reinvested distributions for its ETFs and ETF series of mutual funds available to Canadian investors.Estimated December 2025 Cash DistributionsAs detailed in the table below, unitholders of record as of December 30, 2025, will receive a per-unit cash distribution payable on January 8, 2026.Fund NameTickerType  Estimated Cash DistributionPer Unit($)Payment FrequencyFranklin C ...
Nike And Its Usual Once-A-Year 10% Drop (NYSE:NKE)
Seeking Alpha· 2025-12-19 21:04
As Nike, Inc. ( NKE ) fell more than 10% during after-hours and the day following its Fiscal Q2 report , wiping out $10 billion in market value, I could not help butExcellent academic Finance background and Finance professional with over five years of cumulative experience in Consulting & Audit Firms including a professional Valuation position, FP&A and Controlling positions, and Financial writing.My approach is mostly value-oriented. However, valuation is rarely an appropriate short- to mid-term timing ind ...
Stock market today: Dow, S&P 500, Nasdaq rise as Oracle, Nvidia lead AI trade resurgence
Yahoo Finance· 2025-12-19 21:04
US stocks rose on Friday after snapping a recent losing streak, as signs of cooling inflation and waning AI worries buoyed Wall Street optimism toward the tail end of a topsy-turvy week. The S&P 500 (^GSPC) put on 0.8% and the Nasdaq Composite (^IXIC) gained over 1.3%, building on Thursday's roaring rally. The Dow Jones Industrial Average (^DJI) climbed 0.3%. With the late-week rebound, the S&P 500 and Nasdaq booked weekly wins, rising 0.1% and 0.4%, respectively, in the last full week of trading in 202 ...
KBRA Comments on Burke & Herbert Financial Services Corp.'s Proposed Acquisition of LINKBANCORP, Inc.
Businesswire· 2025-12-19 21:04
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--On December 18, 2025, Burke & Herbert Financial Services Corp. (NASDAQ: BHRB) (KBRA senior unsecured rating of BBB / Stable Outlook), the parent company of Burke and Herbert Bank and Trust Company, announced a definitive merger agreement with LINKBANCORP, Inc. (NASDAQ: LNKB), the parent company of LINKBANK, pursuant to which BHRB will acquire LNKB in an all-stock transaction. The transaction, which had an estimated value of approximately $354 million, is expe ...
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Globenewswire· 2025-12-19 21:04
Reducing inflammation helps create a regenerative environment in the Central Nervous SystemTORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced new laboratory data demonstrating that its proprietary exosomes can significantly reduce inflammatory activity compared to untreated cells and cells treated with a commercially available exosome product. “Inflammation and regeneration are conflicting bi ...